Pharmaceutical composition for angiotensin II-mediated diseases
AssigneeTakeda Chemical Industries, Ltd.
InventorsYoshiyuki Inada, Keiji Kubo
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakeda Chemical Industries, Ltd.
InventorsYoshiyuki Inada, Keiji Kubo
Estimating the term…
This invention relates to a pharmaceutical composition for angiotensin II-mediated diseases, which comprises a compound having angiotensin II antagonistic activity of the formula 1 wherein R1 is H or an optionally substituted hydrocarbon residue; R2 is an optionally esterified carboxyl group; R3 is a group capable of forming an anion or a group convertible thereinto; X is a covalent bond between the 2 phenyl rings or a spacer having a chain length of 1 to 2 atoms as the linear moiety between the adjoining phenylene group and phenyl group; n is 1 or 2; the ring A is a benzene ring having 1 or 2 optional substituents in addition to R2; and Y is a bond, —O—, —S(O)m— (wherein m is 0, 1 or 2) or —N(R4)— (wherein R4 is H or an optionally substituted alkyl group), or a pharmaceutically acceptable salt thereof in combination with a compound having diuretic activity or a compound having calcium antagonistic activity.
A pharmaceutical composition for angiotensin II-mediated diseases, which comprises a compound having angiotensin II antagonistic activity of the formula 16
A method for the prophylaxis or treatment of angiotensin II-mediated diseases in a mammal in need thereof which comprises administering an effective amount of a compound having angiotensin II antagonistic activity represented by the formula (I) 18
Dependencies are inferred from the claim text.